Navigation Links
licensing in Medical News

Addrenex Pharmaceuticals Announces Licensing Agreement With Dream Pharma

RESEARCH TRIANGLE PARK, N.C., Aug. 5 /PRNewswire/ -- Addrenex Pharmaceuticals, a specialty pharmaceutical company dedicated to developing treatments to regulate the adrenergic system, announced today an exclusive partnership with Dream Pharma. In keeping with its long-range plan to ...

Bayer CropScience and Monsanto Sign Cross Licensing Agreement on Herbicide Tolerance Traits in Rapeseed/Canola

MONHEIM, Germany and ST. LOUIS, June 29 /PRNewswire/ -- Bayer CropScience AG and Monsanto Company have agreed to cross license their respective herbicide tolerance traits in rapeseed/canola on a non-exclusive basis for commercialization within their respective branded canola seed businesses. Cano...

KV Pharmaceutical Forms Licensing Partnership with Gedeon Richter

ST. LOUIS and BUDAPEST, Hungary, June 18 /PRNewswire-FirstCall/ -- KV Pharmaceutical Company (NYSE: KVa/KVb) today announced that it has entered into an agreement with Gedeon Richter, Plc. of Budapest, Hungary, and jointly with Gedeon Richter USA for licensing rights to certain of KV's technologie...

Gaiam and Discovery Communications Announce Exclusive Licensing Deal

NEW YORK, June 16 /PRNewswire-FirstCall/ -- Gaiam, Inc., the leading distributor of lifestyle media and fitness accessories, today announced that it has signed an exclusive home video license agreement with Discovery Communications. Under the three-year agreement, Gaiam will release programming fr...

InDex Pharmaceuticals AB Engages PharmaVentures to Facilitate the Licensing of Kappaproct(R) After Phase IIa Trial Achieves Clinical Endpoints Early

OXFORD, England, May 18 /PRNewswire/ -- PharmaVentures Ltd, announced today that it has been engaged by InDex Pharmaceuticals AB to advise and assist in out-licensing its first in class therapeutic, Kappaproct (DIMS 0150), for the treatment of steroid resistant / dependent Inflammatory Bowel Disea...

MMR Information Systems, Inc. Receives Licensing Proposal Involving the Company's Anti-CD20 Antibodies

LOS ANGELES, May 15 /PRNewswire-FirstCall/ -- MMR Information Systems, Inc. (OTC Bulletin Board: MMRF) (the "Company"), which was known as Favrille, Inc. until it acquired its subsidiary MyMedicalRecords, Inc. ("MMR") in January 2009, announced today that it had received a proposal to license cer...

Natural Alternatives International, Inc. Announces Carnosyn(R) Beta-Alanine Licensing Agreement

SAN MARCOS, Calif., March 9 /PRNewswire-FirstCall/ --Natural Alternatives International, Inc. ("NAI") (Nasdaq: NAII ), a leading formulator and manufacturer of customized nutritional supplements, and Compound Solutions, Inc. ("CSI"), a science and marketing based distributor of raw materials to ...

Teikoku Pharma USA and Eisai Co., Ltd. Announce Licensing Agreement for a New 7-Day Transdermal Formulation of Donepezil.

SAN JOSE, Calif., March 9 /PRNewswire/ -- Teikoku Pharma USA Inc., the international specialty pharmaceutical company, announces that it has signed an exclusive worldwide (excluding Japan) licensing agreement with Eisai Co., Ltd. to develop and commercialize a new transdermal formulation of donepe...

CEL-SCI Announces Exclusive Licensing Agreement for Cancer Drug Multikine(R) for Republic of South Africa

VIENNA, Va., March 9 /PRNewswire-FirstCall/ -- CEL-SCI Corporation (NYSE Alternext US: CVM) announced today that it has entered into an exclusive licensing agreement with Byron Biopharma ("Byron") under which CEL-SCI has granted Byron an exclusive license to market and distribute the Company's can...

Bausch & Lomb, Santen Strike Licensing Agreement for IOL Development

ALISO VIEJO, Calif., March 3 /PRNewswire/ -- Bausch & Lomb, the global eye health company, has entered into a licensing agreement with Santen Pharmaceutical Co., Ltd., for the development of certain intraocular lens (IOL) materials. Under the terms of the agreement, Bausch & Lomb has...

More>>

licensing in Medical Technology

Bioniche Life Sciences Inc. and Endo Pharmaceuticals Sign Licensing Agreement for Urocidin(TM)

BELLEVILLE, Ontario and CHADDS FORD, Pa., July 10 /PRNewswire-FirstCall/ -- Bioniche Life Sciences Inc. (TSX: BNC) and Endo Pharmaceuticals (Nasdaq: ENDP ) jointly announced today that Endo has licensed from Bioniche the exclusive rights to develop and market Urocidin(TM) in the U.S. with ...

Moffitt Cancer Center Signs Licensing Agreement with Frantz BioMarkers, LLC

Technology to improve accuracy of ovarian cancer diagnosis TAMPA, Fla., May 14 /PRNewswire/ -- Moffitt Cancer Center and Frantz BioMarkers, LLC have signed a license agreement on phospholipid biomarkers of ovarian cancer. Frantz BioMarkers, which has been granted exclusive worldwide ...

Addrenex Pharmaceuticals Expands Product Pipeline by Licensing New Drug to Treat Narcolepsy

DURHAM, N.C., May 13 /PRNewswire/ -- Addrenex Pharmaceuticals today expanded its pipeline of products aimed at adrenergic regulation with the signing of an agreement to license a new drug for the treatment of narcolepsy, a chronic and debilitating sleep disorder, as well as other neurologic and ps...

Ironwood Announces Linaclotide European Licensing Agreement with Almirall

- Ironwood Will Receive Up To $55 Million in Near Term Payments - CAMBRIDGE, Mass., May 4 /PRNewswire/ -- Ironwood Pharmaceuticals, Inc. today announced that the company has entered into an out-licensing agreement with Laboratorios Almirall, S.A. for European rights to develop and commerciali...

Ipsogen Expands its US Market Presence Through Licensing Agreement With ARUP Laboratories for the Commercialization of JAK2 Molecular Diagnostic Assays

MARSEILLE, France, May 4 /PRNewswire-FirstCall/ -- Ipsogen SA (Alternext - FR0010626028 - ALIPS), a molecular diagnostic company specialized in the development, the manufacturing and the commercialization of diagnostic assays for breast cancer and leukemia, today announces the signature of an ...

CEL-SCI Announces Expansion of Exclusive Licensing Agreement for Cancer Drug Multikine

Partner to Make Direct Investment in CEL-SCI VIENNA, Va., Nov. 3 /PRNewswire-FirstCall/ -- CEL-SCI Corporation (NYSE: CVM ) announced today that it has expanded its exclusive licensing agreement for Multikine(R) with Orient Europharma Co., Ltd. ("Orient Europharma"), a leading pharmaceutica...

Lilly and Deciphera Pharmaceuticals Announce Licensing and Collaboration Agreement

Companies to Study B-Raf Kinase Inhibitors for Cancer Treatments INDIANAPOLIS, Ind. and LAWRENCE, Kan., Oct. 3 /PRNewswire-FirstCall/ -- Eli Lilly and Company (NYSE: LLY ) and privately-held Deciphera Pharmaceuticals, LLC today announced that the two companies have entered into a collabor...

MabVax Therapeutics Closes Two Licensing Agreements With Sloan-Kettering Institute for Cancer Research

SAN DIEGO, Aug. 12 /PRNewswire/ -- MabVax Therapeutics, Inc., a privately held immunotherapeutics discovery and development company focused on the development and commercialization of novel immunotherapies for the treatment of cancer, today announced the completion of two separate licensing ag...

Genzyme and Isis Complete Licensing of Mipomersen

Conference call to be held today at 10 a.m. EDT CAMBRIDGE, Mass., and CARLSBAD, Calif., June 24 /PRNewswire-FirstCall/ -- Genzyme Corp. (Nasdaq: GENZ ) and Isis Pharmaceuticals, Inc. (Nasdaq: ISIS) today announced the finalization of the license and collaboration agreement for mip...

Lilly and TransPharma Medical Announce Licensing and Development Agreement

Lilly Gains Access to Transdermal PTH Program for Osteoporosis INDIANAPOLIS, Ind. and LOD, Israel, June 12 /PRNewswire-FirstCall/ -- Eli Lilly and Company (NYSE: LLY ) and TransPharma Medical Ltd. today announced that the two companies have entered into a licensing and development agreem...
licensing in Medical Products

Dolce & Gabbana Ophthalmic Collection

Description:... and professionalism. Glamour and style. Creativity and cutting-edge design. Dolce & Gabbana and Luxottica, two market-leading companies, signed a new licensing agreement in October 2005.The Dolce & Gabbana brand was formed in 1985 by the famous designer duo, Domenico Dolce and Stefano Gabbana, who blended sen...
Company:Luxottica Group

Full Service Clinical Reference Laboratory

Description:...AP) accreditation. This award indicates that Enzo has passed an extremely rigorous series of inspections far more sophisticated than those mandated by licensing authorities....
Company:Enzo Clinical Labs, Inc.

Just the Facts in Emergency Medicine

Description:... The perfect tool to prepare for in-service or licensing exams, for recertification, or for use as a clinical refresher....
Company:USBMIS Inc.
licensing in Medical Dictionary

Strain

... a deadly alien virus crash-lands in the Arizona desert and quickly kills almost every resident of a nearby town, a team of scientists rushes... licensing is required for this strain . ... Click button to Request this one strain . ... For additional information about this strain , please email Custome...

Physical Therapy

...he physical therapy program at UTC is very fortunate to have an extremely well ... Virginia Board of Physical Therapy Home Page ... Online licensing - Physical Therapy licensees can now renew a license, change an ... Brady Physical Therapy , Physical Therapy clinic in Foster City ......

Mold

... If a moldy smell can be detected, there is mold around. ... Mold licensing Program ... Consumer Mold Information Sheet. DSHS Regulatory Philosophy (pdf 21KB) Information About Mold Problems in Buildings. licensing ... Mold Inspections and Mold ... Mold Remediation. Suggested Lin...

Homeopathy

...ms... A general overview of homeopathy and sources for additional information. ... Controversies Regarding Homeopathy . Side Effects and Risks. licensing and Certification ... The term homeopathy comes from the Greek words homeo, ... Homeopathy seeks to stimulate the body's ability to ... In ho...
licensing in Biological News

bioMETRX, Inc. Completes Exclusive Licensing Agreement With EZ Print, LLC

JERICHO, N.Y., July 30 /PRNewswire-FirstCall/ -- bioMETRX Inc., (OTC Bulletin Board: BMRX), today announced that it has completed an exclusive 15 year licensing agreement with EZ Print, LLC for the advanced remote printing technology acquired through the company's Sequiam asset purchase agreem...

U. Mass Medical School and Carnegie announce licensing agreements with Oxford BioMedica

The University of Massachusetts Medical School and the Carnegie Institution of Washington announced today that they have entered into licensing agreements with Oxford BioMedica (LSE: OXB), a gene therapy company, that grants the company rights to key RNA interference (RNAi) patent rights. Th...

New licensing agreement to maximize AIDS drug development

Longtime collaborators CONRAD and the Biosyn Division of Cellegy Pharmaceuticals, Inc. today announced a non-exclusive licensing agreement to research and develop Biosyn-patented microbicides for the prevention of HIV and other sexually transmitted diseases. The three microbicides covered unde...

Aware, Inc. Reports Second Quarter 2009 Financial Results

...overnment regulations. DSL factors include, but are not limited to: our DSL licensing and DSL test and diagnostic businesses depend upon a limited number of cust...y continue to be a cyclical demand for DSL chipsets; the success of our DSL licensing and test and diagnostics products businesses requires telephone companies t...

Indonesia Now Using MegaMatcher Biometric Technology in Integrated Passport Issuance System

...ents of MegaMatcher can be used on both Microsoft Windows and Linux operating systems. MegaMatcher 3.0 SDK is available with highly competitive licensing options through Neurotechnology or from distributors worldwide. A 30-day trial version with full functionality is also available for download. For mo...

Versartis presents positive preclinical data on 2 product candidates at ENDO 09

... (IL-1ra-rPEG) for treatment of type 1 and type 2 diabetes, at the Endocrine Society's Annual Meeting in Washington, DC. Versartis, through a unique licensing agreement with Amunix, Inc., uses the Amunix proprietary recombinant PEGylation (rPEG) technology to extend the half-life of established biologics. T...

Partnership to accelerate Trudeau Institute discoveries to patient care

...o HRI professional staff and resources both in technology transfer and sponsored research management. HRI brings a well-developed network of corporate licensing and business contacts, funding sources, investors, and researchers. Each of Trudeau's existing and future inventions will be subject to a methodical a...

UGA licenses new Bermuda grass that thrives in sun and shade

... Turf, a Georgia-based company specializing in marketing new turfgrasses, has contracted The Turfgrass Group of Ft. Valley, Ga., to exclusively handle licensing of TifGrand for sod production. TifGrand will be licensed to a selected number of growers beginning in summer 2009; it is expected to be available in ...

Aware, Inc. Reports First Quarter 2009 Financial Results

...overnment regulations. DSL factors include, but are not limited to: our DSL licensing and DSL test and diagnostic businesses depend upon a limited number of cust...y continue to be a cyclical demand for DSL chipsets; the success of our DSL licensing and test and diagnostics products businesses requires telephone companies t...

Association for Molecular Pathology joins ACLU to challenge gene patents

... In 2008, AMP adopted a revised Policy Statement on gene patenting and the licensing of intellectual property that urged an end to the practice of granting pate...to greatly limit those who can access the gene through the use of exclusive licensing agreement. As a result, scientific research has been delayed, limited or ev...
licensing in Biological Technology

NewBridge Pharmaceuticals Announces Licensing of Pylera(R) for Middle East, Africa, Turkey & Caspian Region

DUBAI, United Arab Emirates and SAN FRANCISCO, July 22 /PRNewswire/ -- NewBridge Pharmaceuticals, a specialty pharmaceutical, biologics, and medical device company serving the Middle East, Africa, Turkey & Caspian regions, today announced that it has entered into an exclusive license...

Transgenomic Completes Licensing Option With Dana-Farber Cancer Institute on Cold-PCR for Enrichment of DNA Mutations

OMAHA, Neb., April 7 /PRNewswire-FirstCall/ -- Transgenomic, Inc. (OTC Bulletin Board: TBIO), a leading global biotechnology company, announces that it has completed a licensing option with the Dana-Farber Cancer Institute, Boston, MA with regard to a method known as Cold-PCR. This variation of t...

AEterna Zentaris and Sanofi-Aventis Sign a Development, Commercialization and Licensing Agreement for Cetrorelix in Benign Prostatic Hyperplasia

All amounts are in US dollars QUEBEC CITY, March 6 /PRNewswire-FirstCall/ - AEterna Zentaris Inc. (NASDAQ: AEZS ; TSX: AEZ), a global biopharmaceutical company focused on endocrine therapy and oncology, today announced the signing of a development, commercialization and licensing agreement ...

PDS Biotechnology Corporation Finalizes Commercial Licensing Agreement with Merck Eprova AG to Utilize Merck Eprova's Enantiomers of DOTAP Chloride in Immunotherapies

INDIANAPOLIS, Feb. 24 /PRNewswire/ -- PDS Biotechnology today announced that the company has obtained an exclusive license from Merck Eprova AG to utilize Merck Eprova's proprietary chiral lipid DOTAP Chloride in Versamune(TM)-HPV and other products in development based on the Versamune(TM) te...

Romark and Chugai Pharmaceutical Enter Into Exclusive Licensing Agreement for Nitazoxanide in Japan

Chugai Pharmaceutical Gains Rights to Develop and Market Nitazoxanide for the Treatment of Chronic Hepatitis C TAMPA, Fla., Feb. 17 /PRNewswire/ -- Romark Laboratories, a privately held biopharmaceutical company, and Chugai Pharmaceutical Co. Ltd., a member of the Roche Group, today announced...

Azur Pharma Announces the Licensing of Niravam, Parcopa, Kemstro and Fluxid From UCB

DUBLIN, Ireland, January 9 /PRNewswire/ -- Azur Pharma Limited ("Azur Pharma") today announced that it licensed the exclusive U.S. marketing rights for Niravam(R) (alprazolam orally disintegrating tablets), Parcopa(R) (carbidopa-levodopa orally disintegrating tablets), Kemstro(TM) (baclofen or...

Codexis, Teva in Licensing Agreement Final

REDWOOD CITY, Calif., Jan. 7 /PRNewswire/ -- Codexis, Inc. today announced a licensing agreement with Teva Pharmaceutical Industries Ltd., to produce an important publicly-undisclosed generic product, using a proprietary Codexis biocatalyst. Teva, the largest generic drug manufacturer in the ...

ABAXIS Announces Worldwide Animal Health Licensing Agreement for Rapid Test Technology

UNION CITY, Calif., Jan. 7 /PRNewswire-FirstCall/ -- Abaxis, Inc. (Nasdaq: ABAX ), a medical products company manufacturing point-of-care blood analysis instruments for both the medical and veterinary markets, announced today that it has entered into a license agreement for co-exclusive worldwid...

DSM Biologics and Crucell Announce Commercial PER.C6(R) Licensing Agreement with Gedeon Richter

PARSIPPANY, N.J. and LEIDEN, Netherlands, Nov. 25 /PRNewswire/ -- DSM Biologics, a business unit of DSM Pharmaceutical Products, and Dutch biotechnology company Crucell N.V. (Euronext, Nasdaq: CRXL ; Swiss Exchange: CRX), today announced that Hungary-based Gedeon Richter Plc. signed a commercial...

VisualSonics and Seno Medical Instruments Sign Exclusive Opto-Accoustic Licensing Agreement for Preclinical Research

International Agreement Licenses Seno's Opto-Acoustic Imaging Technology To VisualSonics to Enable Molecular Imaging at the Cellular Level and Aid in the Pursuit of Neurology, Regenerative Medicine, Inflammation, and Cancer Applications TORONTO and SAN ANTONIO, TX, Nov. ...

More>>

licensing in Biological Dictionary

Technology transfer

...fer ... Information about research partnerships and business relationships ... About Technology Transfer . Technology Partnership Agreements. licensing Agreements ... Welcome to the Technology Transfer System of the University of California. ... Technology transfer success stories are told ...
Other Tags
(Date:9/2/2014)... The Jerry Segal Classic to benefit ... 19 at The ACE Club and Green Valley Country ... years, the Classic, organized by the Friends of Jerry ... and services designed to support patients and their families ... “The Segal Classic is a labor of love, my ...
(Date:9/2/2014)... Port Washington, New York (PRWEB) September 02, 2014 ... Waichman LLP announces that Class Counsel has ... and for service awards in the class action ... to Parker Waichman LLP, the Court-Appointed Class Counsel ... Cabraser Heimann & Bernstein, LLP; Audet & Partners, ...
(Date:9/2/2014)... 2014 Lseat.com is one of the most ... its products are user-friendly items; no professional installation is required. ... they can slip right over the cars’ seats. That can ... website is filled with various kinds of practical covers. ... of Jeep leather seat covers . Also, the company ...
(Date:9/2/2014)... California (PRWEB) September 02, 2014 The ... reach USD 8,918.8 million by 2020, growing at an ... to a new study by Grand View Research, Inc. ... and plague modification devices are used for treating peripheral ... formation of atherosclerotic plaques in arteries. These devices are ...
(Date:9/2/2014)... 2014 Eric Jimenez and Leah Ashley ... a revolutionary makeup application device. Designed to improve and ... in the palm of women’s hands to help them ... Color Me’s success lies in its patented technology. With ... of 15,000 pulses per minute, the device applies foundation ...
Breaking Medicine News(10 mins):Health News:The 25th Jerry Segal Classic Returns to Benefit Patients of Magee Rehabilitation Hospital 2Health News:A Proposed Order Has Been Submitted in A Class Action Law Suit Brought Over Flushmate Toilets, Parker Waichman Announces 2Health News:A Proposed Order Has Been Submitted in A Class Action Law Suit Brought Over Flushmate Toilets, Parker Waichman Announces 3Health News:High Quality 1997-2006 JEEP Wrangler TJ Leather Seat Covers From Popular Supplier Lseat.com 2Health News:Peripheral Vascular Devices Market By Product (Peripheral Vascular Stents, PTA Guidewires, Atherectomy Devices) Is Expected To Reach USD 8,918.8 Million By 2020 2Health News:Peripheral Vascular Devices Market By Product (Peripheral Vascular Stents, PTA Guidewires, Atherectomy Devices) Is Expected To Reach USD 8,918.8 Million By 2020 3Health News:Peripheral Vascular Devices Market By Product (Peripheral Vascular Stents, PTA Guidewires, Atherectomy Devices) Is Expected To Reach USD 8,918.8 Million By 2020 4Health News:Peripheral Vascular Devices Market By Product (Peripheral Vascular Stents, PTA Guidewires, Atherectomy Devices) Is Expected To Reach USD 8,918.8 Million By 2020 5Health News:Color Me Launches With Ulta Beauty Revolutionary Makeup Application Device Gets Women Flawless in a Flash 2Health News:Color Me Launches With Ulta Beauty Revolutionary Makeup Application Device Gets Women Flawless in a Flash 3
(Date:9/1/2014)... decisions of the Nomenclature Section of the XVIII International ... 2011. This meeting is held every six years and ... rules for naming algae, fungi and plants get together ... the organisms they study. This is the primary product ... algae, fungi, and plants, which was published in 2012. ...
(Date:8/31/2014)... fast and accurate tool to diagnose tuberculosis in ... developed test (TAM-TB assay) is the first reliable ... The test features excellent specificity, a similar sensitivity ... a blood test. The promising findings are a ... children, particularly in tuberculosis-endemic regions. , The study ...
(Date:8/31/2014)... of the greatest challenges in modern medicine is developing ... with minimal toxicity and side-effects to the patient. Such ... the drug molecule. Ideally, the drug should have a ... so that it binds it with high specificity. Publishing ... a synthetic amino acid that can impact the 3D ...
Breaking Biology News(10 mins):Week-long meeting on naming algae, fungi, and plants recorded for posterity 2New tuberculosis blood test in children is reliable and highly specific 2A new synthetic amino acid for an emerging class of drugs 2A new synthetic amino acid for an emerging class of drugs 3
Other Contents